Chinook Therapeutics (KDNY) News Today → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free KDNY Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineThree Finalists Announced for the 2024 Bloom Burton Awardfinance.yahoo.com - April 21 at 8:42 PMChinook Elementaryusnews.com - November 1 at 3:24 PMChinook Therapeutics, Inc. (NASDAQ:KDNY) is Altium Capital Management LP's 5th Largest Positionmarketbeat.com - September 12 at 6:55 AMChinook Therapeutics, Inc. (NASDAQ:KDNY) Receives Consensus Recommendation of "Hold" from Analystsmarketbeat.com - September 6 at 2:20 AMCitigroup Inc. Boosts Holdings in Chinook Therapeutics, Inc. (NASDAQ:KDNY)marketbeat.com - September 4 at 5:41 AMChinook Therapeutics, Inc. (NASDAQ:KDNY) Shares Sold by C M Bidwell & Associates Ltd.marketbeat.com - September 1 at 9:01 AMCHI Advisors LLC Makes New Investment in Chinook Therapeutics, Inc. (NASDAQ:KDNY)marketbeat.com - August 25 at 3:18 PMChinook Therapeutics, Inc. (NASDAQ:KDNY) Shares Sold by Connor Clark & Lunn Investment Management Ltd.marketbeat.com - August 20 at 5:33 AMBarclays PLC Lowers Stake in Chinook Therapeutics, Inc. (NASDAQ:KDNY)marketbeat.com - August 18 at 4:33 AMmarketbeat.com - August 11 at 6:02 AMQ3 2023 Earnings Forecast for Chinook Therapeutics, Inc. Issued By Wedbush (NASDAQ:KDNY)marketbeat.com - August 10 at 7:11 AMWedbush Downgrades Chinook Therapeutics (KDNY)msn.com - August 8 at 4:50 PMChinook Therapeutics, Inc. (KDNY)uk.finance.yahoo.com - August 2 at 7:27 AMExpert Ratings for Chinook Therapeuticsmarkets.businessinsider.com - August 1 at 4:21 PMWells Fargo Downgrades Chinook Therapeutics (KDNY)msn.com - August 1 at 4:21 PMChinook Therapeutics (NASDAQ:KDNY) Downgraded by Wells Fargo & Company to Equal Weightmarketbeat.com - August 1 at 7:58 AMChinook Therapeutics, Inc. (NASDAQ:KDNY) Shares Sold by Baillie Gifford & Co.marketbeat.com - July 28 at 10:48 AMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, NETI, TALS, QUOTmarkets.businessinsider.com - July 25 at 7:36 AMSG Americas Securities LLC Increases Position in Chinook Therapeutics, Inc. (NASDAQ:KDNY)marketbeat.com - July 20 at 6:15 AMChinook Therapeutics, Inc. (NASDAQ:KDNY) Receives Average Rating of "Hold" from Analystsmarketbeat.com - July 18 at 2:17 AMChinook Therapeutics (NASDAQ: KDNY)fool.com - July 16 at 2:27 PMChinook Therapeutics, Inc. (NASDAQ:KDNY) Position Increased by Hennion & Walsh Asset Management Inc.marketbeat.com - July 7 at 5:51 AMShort Interest in Chinook Therapeutics, Inc. (NASDAQ:KDNY) Drops By 56.4%marketbeat.com - June 30 at 8:42 PMAssenagon Asset Management S.A. Purchases 483,220 Shares of Chinook Therapeutics, Inc. (NASDAQ:KDNY)marketbeat.com - June 29 at 6:33 AMChinook Therapeutics, Inc. (NASDAQ:KDNY) Given Average Recommendation of "Hold" by Analystsmarketbeat.com - June 23 at 2:20 AMChinook: Surprising Acquisition By Novartis, Deal Should Go Throughseekingalpha.com - June 21 at 10:56 AMVictory Capital Management Inc. Grows Holdings in Chinook Therapeutics, Inc. (NASDAQ:KDNY)marketbeat.com - June 21 at 4:33 AMChinook Therapeutics Presents Data from CHK-336 Phase 1 Trial in Healthy Volunteers and New Insights into the Role of Failed Repair in Chronic Kidney Disease at the 60th European Renal Association (ERA) Congressfinance.yahoo.com - June 17 at 9:50 AMMoore Kuehn Encourages NETI, SURF, KDNY, and NEX Investors to Contact Law Firmbenzinga.com - June 16 at 6:13 PMChinook Therapeutics, Inc. (NASDAQ:KDNY) Shares Sold by HealthCor Management L.P.marketbeat.com - June 15 at 6:11 AMCHINOOK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chinook ...businesswire.com - June 14 at 12:42 AMKDNY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Chinook Therapeutics, Inc. Is Fair to Shareholdersbarrons.com - June 13 at 7:41 PMNovartis Stock Screams Value After Chinook Therapeutics Buyout (KDNY)marketbeat.com - June 13 at 8:05 AMNovartis buys Chinook for $3.5 bln in race to treat rare kidney diseasereuters.com - June 13 at 12:42 AMWhy Are Chinook Therapeutics Shares Trading Higher Todaymarkets.businessinsider.com - June 13 at 12:42 AMWhat 6 Analyst Ratings Have To Say About Chinook Therapeuticsmarkets.businessinsider.com - June 12 at 7:39 PMChinook Therapeutics to Present Updated Data from Zigakibart (BION-1301) Phase 1/2 Trial in Patients with IgA Nephropathy (IgAN) at the 60th European Renal Association (ERA) Congressfinance.yahoo.com - June 12 at 7:39 PMNovartis Buys Chinook: M&A To Drive Future Growthseekingalpha.com - June 12 at 4:13 PMChinook Therapeutics (NASDAQ:KDNY) Downgraded to Neutral at Guggenheimmarketbeat.com - June 12 at 2:44 PMWhy Is Chinook Therapeutics (KDNY) Stock Up 58% Today?investorplace.com - June 12 at 10:29 AMGyon Technologies Capital Management LP Makes New $496,000 Investment in Chinook Therapeutics, Inc. (NASDAQ:KDNY)marketbeat.com - June 9 at 10:49 AMChinook Shareholder Action Remindermarkets.businessinsider.com - June 8 at 8:43 PMExodusPoint Capital Management LP Sells 41,701 Shares of Chinook Therapeutics, Inc. (NASDAQ:KDNY)marketbeat.com - June 7 at 8:26 AMPrincipal Financial Group Inc. Grows Stock Holdings in Chinook Therapeutics, Inc. (NASDAQ:KDNY)marketbeat.com - June 5 at 5:07 AMChinook Therapeutics, Inc. (NASDAQ:KDNY) Shares Acquired by Mirae Asset Global Investments Co. Ltd.marketbeat.com - June 2 at 5:34 AMChinook Therapeutics, Inc. (NASDAQ:KDNY) Given Average Recommendation of "Buy" by Brokeragesmarketbeat.com - May 29 at 2:17 AMConnor Clark & Lunn Investment Management Ltd. Sells 51,468 Shares of Chinook Therapeutics, Inc. (NASDAQ:KDNY)marketbeat.com - May 26 at 8:49 AMSwiss National Bank Acquires 5,200 Shares of Chinook Therapeutics, Inc. (NASDAQ:KDNY)marketbeat.com - May 25 at 4:37 AMFY2023 EPS Estimates for Chinook Therapeutics, Inc. (NASDAQ:KDNY) Reduced by Analystmarketbeat.com - May 24 at 6:19 AMAnalysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM), Chinook Therapeutics (KDNY) and Zoetis (ZTS)markets.businessinsider.com - May 23 at 12:44 PM Get Chinook Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KDNY and its competitors with MarketBeat's FREE daily newsletter. Email Address How to camouflage a factory of 53,000 workers (Ad)"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio." Get the full story here. KDNY Media Mentions By Week KDNY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KDNY News Sentiment▼0.670.46▲Average Medical News Sentiment KDNY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KDNY Articles This Week▼11▲KDNY Articles Average Week Get Chinook Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KDNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CRNX News Today RYZB News Today VRNA News Today AKRO News Today ETNB News Today ICVX News Today GRCL News Today IMGN News Today ROIV News Today HCM News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KDNY) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chinook Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
